NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
- ABBREVIATIONS
- CONTRIBUTORS | REVIEWERS
- 1. PURPOSE AND APPLICABILITY
- 2. OVERVIEW AND PRINCIPLES OF THE METHOD
- 3. METHODS
- 3.1. CANDIDATE SUBSTANCE INITIAL SCREENING
- 3.2. SYSTEMATIC EVIDENCE MAP DEVELOPMENT
- 3.3. EVIDENCE MAP REVIEW AND PRE-STUDY EVALUATION
- 3.4. 5-DAY IN VIVO TRANSCRIPTOMIC STUDIES AND ANALYSIS
- 3.5. HUMAN EQUIVALENT DOSE
- 3.6. TRANSCRIPTOMIC REFERENCE VALUES
- 3.7. ETAP REPORTING
- 3.8. INTERNAL AND EXTERNAL REVIEW OF ETAPs
- 4. COMPARISON OF TRANSCRIPTOMIC REFERENCE VALUES WITH TRADITIONAL RfDs
- 5. REFERENCES
- 6. APPENDIX – STANDARD TEMPLATE
Final Report
Contributors
Reeder Sams
CCTE Deputy Center Director
Sid Hunter
CCTE/BCTD Division Director
Wayne Cascio
CPHEA Center Director
Kay Holt
CPHEA Deputy Center Director
Samantha Jones
CPHEA Associate Director
Ravi Subramaniam
CPHEA/CPAD/TEABD Branch Chief
Glenn Rice
CPHEA/CPAD/TEABC Branch Chief
John Bucher
NTP/DTT/NIEHS/NIH
Timothy Buckley
EPA/ORD/CCTE
Peter Egeghy
EPA/ORD/CCTE
Katie Paul-Friedman
EPA/ORD/CCTE
Joshua Harrill
EPA/ORD/CCTE
Sid Hunter
EPA/ORD/CCTE
Kristin Isaacs
EPA/ORD/CCTE
Richard Judson
EPA/ORD/CCTE
Jonathan Kaiser
EPA/ORD/CPHEA
Scott Masten
NTP/DTT/NIEHS/NIH
Fred Parham
NTP/DTT/NIEHS/NIH
Dan Petersen
EPA/ORD/CPHEA
Allison Phillips
EPA/ORD/CPHEA
Jon Sobus
EPA/ORD/CCTE
Daniel Villeneuve
EPA/ORD/CCTE
Paul White
EPA/ORD/CPHEA
Antony Williams
EPA/ORD/CCTE
George Woodall
EPA/ORD/CPHEA
Jay Zhao
EPA/ORD/CPHEA
DISCLAIMER: This document has been reviewed in accordance with the U.S. Environmental Protection Agency’s (EPA) peer and administrative review policies and approved for publication. Peer review was performed by the EPA Board of Scientific Counselors and was subject to public comment. Any mention of trade names, products, or services does not imply an endorsement by the U.S. government or the EPA. EPA does not endorse any commercial products, services, or enterprises.